Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Entacapone (OR-611) is a selective and reversible inhibitor of catechol-O-methyltransferase (COMT).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 30.00 | |
10 mg | In stock | $ 47.00 | |
25 mg | In stock | $ 73.00 | |
50 mg | In stock | $ 97.00 | |
100 mg | In stock | $ 147.00 | |
200 mg | In stock | $ 218.00 | |
500 mg | In stock | $ 369.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 45.00 |
Description | Entacapone (OR-611) is a selective and reversible inhibitor of catechol-O-methyltransferase (COMT). |
Targets&IC50 | COMT:151 nM |
In vivo | In various tissues, such as the liver, duodenum, kidney, and lung, Entacapone inhibits the activity of catechol-O-methyltransferase (COMT). Additionally, in PC12 cells, Entacapone can suppress extracellular cytotoxicity induced by the aggregation of α-syn and β-amyloid (Aβ). |
Synonyms | OR-611 |
Molecular Weight | 305.29 |
Formula | C14H15N3O5 |
CAS No. | 130929-57-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 57 mg/mL (186.7 mM)
Ethanol: 2 mg/mL (6.55 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Entacapone 130929-57-6 Metabolism Transferase OR-611 COMT OR 611 metabolic disorder inhibit OR611 Inhibitor ?FTO?knockdown Parkinson's disease inhibitor